
Marksans Pharma Q2 FY27 Results: Consolidated Net Profit ₹144 Crore on Total Income of ₹958 Crore
Marksans Pharma (NSE: MARKSANS) reported consolidated total income of ₹958.32 crore and consolidated net profit of ₹143.53 crore for the quarter ended 30 Sep 2026, it said in a filing on 04 Nov 2026. Standalone total income was ₹371.05 crore and standalone net profit was ₹85.54 crore for the same quarter.
- Earnings
- pharmaceuticals